MUSIANI, DANIELE
MUSIANI, DANIELE
Cisplatin unveils cancer cell addiction to the non-oncogene CDT2
2009-01-01 Olivero M; Dettori D; Lorenzato A; Martino C; Musiani D; Orlando G; Di Renzo MF
CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin
2010-01-01 Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF
Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF
2017-01-01 Konda, John D.; Olivero, Martina; Musiani, Daniele; Lamba, Simona; Di Renzo, Maria F.
Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy.
2014-01-01 Musiani, Daniele; Konda, John David; Pavan, Simona; Torchiaro, Erica; Sassi, Francesco; Noghero, Alessio; Erriquez, Jessica; Perera, Timothy; Olivero, Martina; Di Renzo, Maria Flavia
HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel
2012-01-01 Pavan S ; Musiani D ; Torchiaro E ; Migliardi G ; Olivero M; Di Renzo MF
HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.
2014-01-01 Pavan S;Musiani D;Torchiaro E;Migliardi G;Gai M;Di Cunto F;Erriquez J;Olivero M;Di Renzo MF
PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy
2014-01-01 Musiani, Daniele; Hammond, Dean E.; Cirillo, Luca; Erriquez, Jessica; Olivero, Martina; Clague, Michael J.; Di Renzo, Maria Flavia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cisplatin unveils cancer cell addiction to the non-oncogene CDT2 | 2009 | Olivero M; Dettori D; Lorenzato A; Martino C; Musiani D; Orlando G; Di Renzo MF | |
| CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin | 2010 | Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF | |
| Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF | 2017 | Konda, John D.; Olivero, Martina; Musiani, Daniele; Lamba, Simona; Di Renzo, Maria F. | |
| Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. | 2014 | Musiani, Daniele; Konda, John David; Pavan, Simona; Torchiaro, Erica; Sassi, Francesco; Noghero, Alessio; Erriquez, Jessica; Perera, Timothy; Olivero, Martina; Di Renzo, Maria Flavia | |
| HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel | 2012 | Pavan S ; Musiani D ; Torchiaro E ; Migliardi G ; Olivero M; Di Renzo MF | |
| HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor. | 2014 | Pavan S;Musiani D;Torchiaro E;Migliardi G;Gai M;Di Cunto F;Erriquez J;Olivero M;Di Renzo MF | |
| PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy | 2014 | Musiani, Daniele; Hammond, Dean E.; Cirillo, Luca; Erriquez, Jessica; Olivero, Martina; Clague, Michael J.; Di Renzo, Maria Flavia |